In ₹ Crore except Per Share Latest Annual | VIYASH FY26 | AARTIDRUGS FY26 | YATHARTH FY26 | THYROCARE FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 63.33× | ◆ 20.46× | 53.91× | 54.33× | 53.91× +17% | |
| P/B | 3.63× | ◆ 2.57× | 5.23× | 15.15× | 5.23× -31% | |
| EV/EBITDA | 17.62× | ◆ 14.74× | 32.47× | 33.17× | 32.47× -46% | |
| Market Cap | ₹11,314 Cr | ₹3,988 Cr | ₹9,453 Cr | ₹8,882 Cr | ₹8,882 Cr +27% | |
| Growth | ||||||
| Revenue CAGR 3Y | 34.02% | -1.89% | ◆ 48.11% | 16.33% | 16.33% +108% | |
| Revenue CAGR 5Y | ◆ 20.23% | 3.55% | — | 10.88% | 7.21% +180% | |
| Net Income CAGR 3Y | — | 5.43% | ◆ 38.45% | 36.27% | 36.27% | |
| Revenue YoY (latest Q) | ◆ 114.39% | 19.01% | 52.33% | 24.34% | 24.34% +370% | |
| Net Income YoY (latest Q) | ◆ 351.28% | -7.12% | 8.05% | 34.06% | 8.05% +4264% | |
| Profitability | ||||||
| EBITDA Margin | 19.08% | 12.05% | 24.20% | ◆ 31.61% | 24.20% -21% | |
| Net Income Margin | 6.57% | 7.60% | 14.11% | ◆ 19.64% | 14.11% -53% | |
| Return on Common Equity | 5.69% | 12.58% | 9.42% | ◆ 27.82% | 12.58% -55% | |
| Return on Capital Employed | 11.38% | 12.80% | 9.74% | ◆ 31.92% | 12.80% -11% | |
| Return on Assets | 4.85% | 6.92% | 7.46% | ◆ 21.79% | 7.46% -35% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.14× | 0.37× | 0.14× | ◆ 0.00× | 0.14× +0% | |
| Interest Coverage | 6.05× | 7.19× | 31.26× | ◆ 72.66× | 31.26× -81% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹3,420 Cr | ₹2,565 Cr | ₹1,207 Cr | ₹829 Cr | ₹1,207 Cr +183% | |
| Net Income | ₹225 Cr | ₹195 Cr | ₹170 Cr | ₹163 Cr | ₹170 Cr +32% | |
| Total Assets | ₹4,628 Cr | ₹2,815 Cr | ₹2,282 Cr | ₹747 Cr | ₹2,282 Cr +103% | |
| EPS | ₹4.09 | ₹21.36 | ₹18.2 | ₹10.27 | ₹18.2 -78% | |
| Book Value per Share | ₹71.3 | ₹169.74 | ₹187.55 | ₹36.82 | ₹169.74 -58% | |